In breast cancer, its prognostic impact appears to depend on context: some studies of early-stage breast cancer paradoxically noted that IL-10 was associated with better prognosis in certain hormone receptor-positive cases, possibly due to IL-10 reducing harmful inflammation. This evidence concerns the gene IL10 and breast cancer.